Acetazolamide Market
Acetazolamide is one of the most favored medicine for glaucoma cases as it aids in dismissing prodromes and decreases threat of severe side effects amid sufferers of glaucoma. Acetazolamide is vended in various skill names comprising AZM, Diamox, Evamox, Acemox, and Setacar. The medicine is utilized to cure glaucoma, epilepsy, ailment, and cardiovascular attacks persuaded edema.
Moreover, major companies are involved in approving acetazolamide-based goods along with rising official acceptance for the similar in the market. For example, in November 2017, SPG Pte. Ltd. — secondary of SSL—gained acceptance from the U.S. FDA for acetazolamide capsules, 125 mg and 250 mg, a common brand of Diamox capsules. Acetazolamide capsule is utilized to obstruct and decrease the prodormes of AMS and cure a specific form of optic difficulty. In the U.S., organizations acetazolamide capsules are promoted by SPI. Moreover, in November 2012, Sagent pharma announced acetazolamide for syringe, particular for adjunctive therapy of edema owing to CHF, medicine-induced edema, centrencephalic epilepsy, and CSG, secondary glaucoma, and preoperatively in ACCG.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables& Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-pdf/2396
Acetazolamide Market: Key takeaways
- The global acetazolamide market is anticipated to increase at a CAGR of 4.8% over the predicted duration (2018 – 2026), due to huge frequency of glaucoma, edema, and its linked threat reasons such as mellitus, family history of glaucoma, hypertension, amongst others.
- Among formulation, capsules section responsible for main market share in 2017. Acetazolamide is mainly utilized in the therapy of glaucoma and huge ailment, due to rising dose choice and medical efficacy of acetazolamide. For example, as per record generated in the BMJ journal in September 2012, regular dose of 250 mg, 500 mg, and 750 mg acetazolamide was seen to be efficient in curing AMS.
- Among applications, glaucoma section held main market share, in 2017. Acetazolamide is launched and rousingly used as CAI in the therapy of glaucoma, by providing substantial stress release result.
- Among distribution channel, healthcare pharma segment keeps main market share in 2017. Healthcare pharma act as main channel in supply of acetazolamide medicines to glaucoma sufferers who are cured in clinics.
- Major players involved in the acetazolamide market are Novast Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Strides Shasun Limited, Accord Healthcare Ltd. (Intas Pharmaceuticals Limited), Lannett Company, Inc., Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc. Heritage Pharmaceuticals Inc., Nostrum Laboratories Inc.,), and X-GEN Pharmaceuticals, Inc.
Purchase This Premium Report With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/2396
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Formulation
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Epidemiology
- Key Developments
- Drug Approvals and Launches
- Strategic Collaborations & Acquisitions
- Regulatory Scenario
- Pipeline Analysis
- Market Dynamics
- Global Acetazolamide Market, By Formulation, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Introduction
- Global Acetazolamide Market, By Application, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Epilepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Drug indicted Edema
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Altitude Sickness
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Fluid Retention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Seizures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Introduction
- Global Acetazolamide Market, By Distribution Channel, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/acetazolamide-market-to-surpass-us-2790-million-by-2026-1231
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837